Xiamen Kingdomway Group Co
SZSE:002626
Intrinsic Value
Xiamen Kingdomway Group Co. engages in the research, development, manufacture and distribution of nutrition enhancers and bio-medical products. [ Read More ]
The intrinsic value of one Xiamen Kingdomway Group Co stock under the Base Case scenario is 20.23 CNY. Compared to the current market price of 15.67 CNY, Xiamen Kingdomway Group Co is Undervalued by 23%.
Valuation Backtest
Xiamen Kingdomway Group Co
Run backtest to discover the historical profit from buying and selling Xiamen Kingdomway Group Co stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Xiamen Kingdomway Group Co
Current Assets | 2.4B |
Cash & Short-Term Investments | 1.1B |
Receivables | 396.3m |
Other Current Assets | 893.3m |
Non-Current Assets | 3.4B |
Long-Term Investments | 782.3m |
PP&E | 1.5B |
Intangibles | 788.3m |
Other Non-Current Assets | 281.9m |
Current Liabilities | 975.4m |
Accounts Payable | 234.5m |
Accrued Liabilities | 46.3m |
Short-Term Debt | 109.2m |
Other Current Liabilities | 585.4m |
Non-Current Liabilities | 985.7m |
Long-Term Debt | 703.9m |
Other Non-Current Liabilities | 281.8m |
Earnings Waterfall
Xiamen Kingdomway Group Co
Revenue
|
3B
CNY
|
Cost of Revenue
|
-1.9B
CNY
|
Gross Profit
|
1.1B
CNY
|
Operating Expenses
|
-933.2m
CNY
|
Operating Income
|
184.7m
CNY
|
Other Expenses
|
-33m
CNY
|
Net Income
|
151.6m
CNY
|
Free Cash Flow Analysis
Xiamen Kingdomway Group Co
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Xiamen Kingdomway Group Co's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Xiamen Kingdomway Group Co's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Xiamen Kingdomway Group Co's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Xiamen Kingdomway Group Co's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Xiamen Kingdomway Group Co
According to Wall Street analysts, the average 1-year price target for Xiamen Kingdomway Group Co is 23.46 CNY with a low forecast of 23.23 CNY and a high forecast of 24.15 CNY.
Shareholder Return
Price
Xiamen Kingdomway Group Co
Average Annual Return | 24.87% |
Standard Deviation of Annual Returns | 53.65% |
Max Drawdown | -80% |
Market Capitalization | 9.6B CNY |
Shares Outstanding | 609 845 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Xiamen Kingdomway Group Co. engages in the research, development, manufacture and distribution of nutrition enhancers and bio-medical products. The company is headquartered in Xiamen, Fujian and currently employs 2,409 full-time employees. The company went IPO on 2011-10-28. The firm mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Xiamen Kingdomway Group Co stock under the Base Case scenario is 20.23 CNY.
Compared to the current market price of 15.67 CNY, Xiamen Kingdomway Group Co is Undervalued by 23%.